Logo image of GEHC

GE HEALTHCARE TECHNOLOGY (GEHC) Stock Fundamental Analysis

USA - NASDAQ:GEHC - US36266G1076 - Common Stock

74.91 USD
+0.91 (+1.23%)
Last: 9/19/2025, 8:12:37 PM
74.91 USD
0 (0%)
After Hours: 9/19/2025, 8:12:37 PM
Fundamental Rating

5

Taking everything into account, GEHC scores 5 out of 10 in our fundamental rating. GEHC was compared to 190 industry peers in the Health Care Equipment & Supplies industry. While GEHC belongs to the best of the industry regarding profitability, there are concerns on its financial health. GEHC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year GEHC was profitable.
In the past year GEHC had a positive cash flow from operations.
Each year in the past 5 years GEHC has been profitable.
In the past 5 years GEHC always reported a positive cash flow from operatings.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

GEHC has a better Return On Assets (6.31%) than 85.34% of its industry peers.
GEHC has a Return On Equity of 23.07%. This is amongst the best in the industry. GEHC outperforms 95.29% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.93%, GEHC belongs to the top of the industry, outperforming 86.39% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for GEHC is in line with the industry average of 8.43%.
Industry RankSector Rank
ROA 6.31%
ROE 23.07%
ROIC 7.93%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

GEHC's Profit Margin of 11.22% is amongst the best of the industry. GEHC outperforms 84.82% of its industry peers.
GEHC's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 13.82%, GEHC belongs to the top of the industry, outperforming 81.15% of the companies in the same industry.
GEHC's Operating Margin has been stable in the last couple of years.
GEHC has a Gross Margin of 41.55%. This is in the lower half of the industry: GEHC underperforms 65.97% of its industry peers.
GEHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.82%
PM (TTM) 11.22%
GM 41.55%
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GEHC is still creating some value.
The number of shares outstanding for GEHC has been increased compared to 1 year ago.
Compared to 1 year ago, GEHC has an improved debt to assets ratio.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

GEHC has an Altman-Z score of 1.84. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
GEHC has a Altman-Z score (1.84) which is comparable to the rest of the industry.
GEHC has a debt to FCF ratio of 6.59. This is a slightly negative value and a sign of low solvency as GEHC would need 6.59 years to pay back of all of its debts.
GEHC has a better Debt to FCF ratio (6.59) than 77.49% of its industry peers.
GEHC has a Debt/Equity ratio of 0.86. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
GEHC's Debt to Equity ratio of 0.86 is on the low side compared to the rest of the industry. GEHC is outperformed by 74.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 6.59
Altman-Z 1.84
ROIC/WACC1.01
WACC7.85%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

GEHC has a Current Ratio of 1.16. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
GEHC's Current ratio of 1.16 is on the low side compared to the rest of the industry. GEHC is outperformed by 83.25% of its industry peers.
A Quick Ratio of 0.93 indicates that GEHC may have some problems paying its short term obligations.
GEHC's Quick ratio of 0.93 is on the low side compared to the rest of the industry. GEHC is outperformed by 79.58% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.93
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.50% over the past year.
GEHC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.32% yearly.
The Revenue has been growing slightly by 2.30% in the past year.
The Revenue has been growing slightly by 3.41% on average over the past years.
EPS 1Y (TTM)14.5%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%6%
Revenue 1Y (TTM)2.3%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%3.47%

3.2 Future

GEHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.34% yearly.
GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.43% yearly.
EPS Next Y2.72%
EPS Next 2Y5.97%
EPS Next 3Y7.93%
EPS Next 5Y5.34%
Revenue Next Year3.92%
Revenue Next 2Y4.29%
Revenue Next 3Y4.42%
Revenue Next 5Y3.43%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.08, GEHC is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 85.86% of the companies listed in the same industry.
GEHC is valuated rather cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 14.86 indicates a correct valuation of GEHC.
86.39% of the companies in the same industry are more expensive than GEHC, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.86. GEHC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.08
Fwd PE 14.86
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

GEHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GEHC is cheaper than 85.34% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GEHC is valued cheaper than 84.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.85
EV/EBITDA 12.26
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GEHC does not grow enough to justify the current Price/Earnings ratio.
GEHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.91
PEG (5Y)3.02
EPS Next 2Y5.97%
EPS Next 3Y7.93%

3

5. Dividend

5.1 Amount

GEHC has a yearly dividend return of 0.19%, which is pretty low.
Compared to an average industry Dividend Yield of 1.74, GEHC pays a better dividend. On top of this GEHC pays more dividend than 90.58% of the companies listed in the same industry.
With a Dividend Yield of 0.19, GEHC pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

2.63% of the earnings are spent on dividend by GEHC. This is a low number and sustainable payout ratio.
DP2.63%
EPS Next 2Y5.97%
EPS Next 3Y7.93%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (9/19/2025, 8:12:37 PM)

After market: 74.91 0 (0%)

74.91

+0.91 (+1.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners80.15%
Inst Owner Change-0.97%
Ins Owners0.28%
Ins Owner Change0.09%
Market Cap34.20B
Analysts81.48
Price Target88.75 (18.48%)
Short Float %1.62%
Short Ratio2.08
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.63%
Div Incr Years1
Div Non Decr Years1
Ex-Date07-25 2025-07-25 (0.035)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.83%
Min EPS beat(2)8.42%
Max EPS beat(2)13.24%
EPS beat(4)4
Avg EPS beat(4)10.08%
Min EPS beat(4)6.17%
Max EPS beat(4)13.24%
EPS beat(8)7
Avg EPS beat(8)6.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.33%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)0.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-2.17%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.74%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.39%
EPS NY rev (1m)0%
EPS NY rev (3m)11.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.86%
Valuation
Industry RankSector Rank
PE 16.08
Fwd PE 14.86
P/S 1.71
P/FCF 21.85
P/OCF 17.14
P/B 3.52
P/tB N/A
EV/EBITDA 12.26
EPS(TTM)4.66
EY6.22%
EPS(NY)5.04
Fwd EY6.73%
FCF(TTM)3.43
FCFY4.58%
OCF(TTM)4.37
OCFY5.83%
SpS43.73
BVpS21.27
TBVpS-10.79
PEG (NY)5.91
PEG (5Y)3.02
Profitability
Industry RankSector Rank
ROA 6.31%
ROE 23.07%
ROCE 10.72%
ROIC 7.93%
ROICexc 9.27%
ROICexgc 27.67%
OM 13.82%
PM (TTM) 11.22%
GM 41.55%
FCFM 7.84%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexcg growth 3Y-14.77%
ROICexcg growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 6.59
Debt/EBITDA 2.5
Cap/Depr 75.84%
Cap/Sales 2.15%
Interest Coverage 5.15
Cash Conversion 59.96%
Profit Quality 69.83%
Current Ratio 1.16
Quick Ratio 0.93
Altman-Z 1.84
F-Score6
WACC7.85%
ROIC/WACC1.01
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)14.5%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%6%
EPS Next Y2.72%
EPS Next 2Y5.97%
EPS Next 3Y7.93%
EPS Next 5Y5.34%
Revenue 1Y (TTM)2.3%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%3.47%
Revenue Next Year3.92%
Revenue Next 2Y4.29%
Revenue Next 3Y4.42%
Revenue Next 5Y3.43%
EBIT growth 1Y12.47%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year13.59%
EBIT Next 3Y10.21%
EBIT Next 5Y8.87%
FCF growth 1Y-8%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-3.39%
OCF growth 3Y6.68%
OCF growth 5Y1.2%